NASDAQ: $REGN A New Chapter for FOP Patients For individuals living with Fibrodysplasia Ossificans Progressiva (FOP), a rare and debilitating genetic disorder, the medical landscape has just shifted significantly. The FDA has officially approved Pasatru (garetosmab), a new therapeutic option designed to help manage this challenging condition. Understanding FOP FOP is a rare genetic condition…